Business · 19/05/2016Updated: 10/17/2026 · 1 min read
FDA Renews Drug Safety and Risk Management Advisory Committee for 2 Years
Summary
The FDA Commissioner has renewed the committee for an additional 2 years, extending its term until May 31, 2018, in the public interest.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →